Manufacturing, Specialty Dosage Forms

Catalent Invests $175 Million to Expand Manufacturing Capabilities and Capacity in US Facility

May 20, 2022

Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.

Understanding Pharmaceutical Compounding from Multiple Perspectives

April 02, 2022

Meeting patient needs and achieving high quality are common goals for all stakeholders.

Catalent Completes $30 Million Project for Biopharmaceutical Development and Manufacturing in Limoges, France

March 17, 2022

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.

Spray Drying Finds Growing Use for ASDs

February 01, 2022

CDMOs offer expertise and capacity for spray drying.

Researchers Cite Positive Results in COVID-19 Microneedle Patch Trial

September 24, 2021

Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.

Understanding Combination Product Regulations

September 16, 2021

Considering interactions and understanding regulatory requirements are crucial when developing a drug or biologic product for use with a medical device.

SAHPRA Authorizes ImmunityBio to Proceed with Trial of T-Cell Vaccine as Booster Against COVID-19

July 16, 2021

ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.

SPI Pharma Introduces Platform for Orally Disintegrating Tablets

July 12, 2021

UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.

Combining Multiparticulates and 3DP for Patient-Centric Dosage Forms

May 03, 2021

Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.

Nanoform and Aprecia Explore 3D-Printed Drug Dosage Forms

April 21, 2021

The collaboration will evaluate Nanoform’s fast dissolution nanoparticles in Aprecia’s ZipDose 3DP technology platform for buccal and oral drug delivery.